全文获取类型
收费全文 | 1581篇 |
免费 | 109篇 |
出版年
2023年 | 5篇 |
2022年 | 5篇 |
2021年 | 41篇 |
2020年 | 24篇 |
2019年 | 22篇 |
2018年 | 32篇 |
2017年 | 36篇 |
2016年 | 59篇 |
2015年 | 79篇 |
2014年 | 92篇 |
2013年 | 123篇 |
2012年 | 145篇 |
2011年 | 133篇 |
2010年 | 84篇 |
2009年 | 71篇 |
2008年 | 96篇 |
2007年 | 80篇 |
2006年 | 102篇 |
2005年 | 75篇 |
2004年 | 91篇 |
2003年 | 77篇 |
2002年 | 60篇 |
2001年 | 10篇 |
2000年 | 11篇 |
1999年 | 13篇 |
1998年 | 11篇 |
1997年 | 5篇 |
1996年 | 7篇 |
1995年 | 16篇 |
1994年 | 7篇 |
1993年 | 8篇 |
1992年 | 12篇 |
1991年 | 7篇 |
1990年 | 9篇 |
1989年 | 4篇 |
1987年 | 4篇 |
1985年 | 5篇 |
1984年 | 2篇 |
1983年 | 5篇 |
1980年 | 3篇 |
1979年 | 3篇 |
1978年 | 1篇 |
1977年 | 3篇 |
1975年 | 1篇 |
1974年 | 2篇 |
1972年 | 1篇 |
1971年 | 1篇 |
1967年 | 2篇 |
1961年 | 1篇 |
1959年 | 1篇 |
排序方式: 共有1690条查询结果,搜索用时 890 毫秒
991.
Arick C. Park Guorui Huang Ewa Jankowska-Gan Dawiyat Massoudi John F. Kernien Dario A. Vignali Jeremy A. Sullivan David S. Wilkes William J. Burlingham Daniel S. Greenspan 《The Journal of biological chemistry》2016,291(7):3359-3370
We have shown previously that collagen V (col(V)) autoimmunity is a consistent feature of atherosclerosis in human coronary artery disease and in the Apoe−/− mouse model. We have also shown sensitization of Apoe−/− mice with col(V) to markedly increase the atherosclerotic burden, providing evidence of a causative role for col(V) autoimmunity in atherosclerotic pathogenesis. Here we sought to determine whether induction of immune tolerance to col(V) might ameliorate atherosclerosis, providing further evidence for a causal role for col(V) autoimmunity in atherogenesis and providing insights into the potential for immunomodulatory therapeutic interventions. Mucosal inoculation successfully induced immune tolerance to col(V) with an accompanying reduction in plaque burden in Ldlr−/− mice on a high-cholesterol diet. The results therefore demonstrate that inoculation with col(V) can successfully ameliorate the atherosclerotic burden, suggesting novel approaches for therapeutic interventions. Surprisingly, tolerance and reduced atherosclerotic burden were both dependent on the recently described IL-35 and not on IL-10, the immunosuppressive cytokine usually studied in the context of induced tolerance and amelioration of atherosclerotic symptoms. In addition to the above, using recombinant protein fragments, we were able to localize two epitopes of the α1(V) chain involved in col(V) autoimmunity in atherosclerotic Ldlr−/− mice, suggesting future courses of experimentation for the characterization of such epitopes. 相似文献
992.
Sandra E. Gomez-Mejiba Zili Zhai Maria S. Gimenez Michael T. Ashby Jaya Chilakapati Kirk Kitchin Ronald P. Mason Dario C. Ramirez 《The Journal of biological chemistry》2010,285(26):20062-20071
Myeloperoxidase (MPO) released by activated neutrophils can initiate and promote carcinogenesis. MPO produces hypochlorous acid (HOCl) that oxidizes the genomic DNA in inflammatory cells as well as in surrounding epithelial cells. DNA-centered radicals are early intermediates formed during DNA oxidation. Once formed, DNA-centered radicals decay by mechanisms that are not completely understood, producing a number of oxidation products that are studied as markers of DNA oxidation. In this study we employed the 5,5-dimethyl-1-pyrroline N-oxide-based immuno-spin trapping technique to investigate the MPO-triggered formation of DNA-centered radicals in inflammatory and epithelial cells and to test whether resveratrol blocks HOCl-induced DNA-centered radical formation in these cells. We found that HOCl added exogenously or generated intracellularly by MPO that has been taken up by the cell or by MPO newly synthesized produces DNA-centered radicals inside cells. We also found that resveratrol passed across cell membranes and scavenged HOCl before it reacted with the genomic DNA, thus blocking DNA-centered radical formation. Taken together our results indicate that the formation of DNA-centered radicals by intracellular MPO may be a useful point of therapeutic intervention in inflammation-induced carcinogenesis. 相似文献
993.
994.
Maria Gabriella Brasca Clara Albanese Rachele Alzani Raffaella Amici Nilla Avanzi Dario Ballinari James Bischoff Daniela Borghi Elena Casale Valter Croci Francesco Fiorentini Antonella Isacchi Ciro Mercurio Marcella Nesi Paolo Orsini Wilma Pastori Enrico Pesenti Paolo Pevarello Patrick Roussel Mario Varasi Marina Ciomei 《Bioorganic & medicinal chemistry》2010,18(5):1844-1853
We have recently reported CDK inhibitors based on the 6-substituted pyrrolo[3,4-c]pyrazole core structure. Improvement of inhibitory potency against multiple CDKs, antiproliferative activity against cancer cell lines and optimization of the physico-chemical properties led to the identification of highly potent compounds. Compound 31 (PHA-793887) showed good efficacy in the human ovarian A2780, colon HCT-116 and pancreatic BX-PC3 carcinoma xenograft models and was well tolerated upon daily treatments by iv administration. It was identified as a drug candidate for clinical evaluation in patients with solid tumors. 相似文献
995.
Lon D. Ridgway Michael D. Wetzel Dario Marchetti 《Journal of cellular biochemistry》2010,111(5):1299-1309
Mechanisms of brain metastatic melanoma (BMM) remain largely unknown. Understanding the modulation of signaling pathways that alter BMM cell invasion and metastasis is critical to develop new therapies for BMM. Heparanase has been widely implicated in cancer and is the dominant mammalian endoglycosidase which degrades heparan sulfate chains of proteoglycans (HSPG) including syndecans (SDCs). Recent findings also indicate that heparanase possesses non‐enzymatic functions in its latent form. We hypothesized that extracellular heparanase modulates BMM cell signaling by involving SDC1/4 carboxy terminal—associated proteins and downstream targets. We digested BMM cell surface HS with human recombinant active or latent heparanase to delineate their effects on cytoskeletal dynamics and cell invasiveness. We identified the small GTPase guanine nucleotide exchange factor‐H1 (GEF‐H1) as a new component of a SDC signaling complex that is differentially expressed in BMM cells compared to corresponding non‐metastatic counterparts. Second, knockdown of GEF‐H1, SDC1, or SDC4 decreased BMM cell invasiveness and GEF‐H1 modulated small GTPase activity of Rac1 and RhoA in conjunction with heparanase treatment. Third, both active and latent forms of heparanase affected Rac1 and RhoA activity; notably increasing RhoA activity. Both forms of heparanase were found to mediate the expression and subcellular localization of GEF‐H1, and treatment of BMM with latent heparanase modulated SDC1/4 gene expression. Finally, treatment with exogenous heparanase downregulated BMM cell invasion. These studies indicate the relevance of heparanase signaling pathways in BMM progression, and provide insights into the molecular mechanisms regulating HSPG signaling in response to exogenous heparanase. J. Cell. Biochem. 111: 1299–1309, 2010. © 2010 Wiley‐Liss, Inc. 相似文献
996.
997.
A flying insect must travel to find food, mates and sites for oviposition, but for a small animal in a turbulent world this means dealing with frequent unplanned deviations from course. We measured a fly''s sensory-motor impulse response to perturbations in optic flow. After an abrupt change in its apparent visual position, a fly generates a compensatory dynamical steering response in the opposite direction. The response dynamics, however, may be influenced by superimposed background velocity generated by the animal''s flight direction. Here we show that constant forward velocity has no effect on the steering responses to orthogonal sideslip perturbations, whereas constant parallel sideslip substantially shortens the lags and relaxation times of the linear dynamical responses. This implies that for flies stabilizing in sideslip, the control effort is strongly affected by the direction of background motion. 相似文献
998.
Lokesh Gakhar Jennifer A. Bartlett Jon Penterman Dario Mizrachi Pradeep K. Singh Rama K. Mallampalli S. Ramaswamy Paul B. McCray Jr. 《PloS one》2010,5(2)
Background
The PLUNC (“Palate, lung, nasal epithelium clone”) protein is an abundant secretory product of epithelia present throughout the conducting airways of humans and other mammals, which is evolutionarily related to the lipid transfer/lipopolysaccharide binding protein (LT/LBP) family. Two members of this family - the bactericidal/permeability increasing protein (BPI) and the lipopolysaccharide binding protein (LBP) - are innate immune molecules with recognized roles in sensing and responding to Gram negative bacteria, leading many to propose that PLUNC may play a host defense role in the human airways.Methodology/Principal Findings
Based on its marked hydrophobicity, we hypothesized that PLUNC may be an airway surfactant. We found that purified recombinant human PLUNC greatly enhanced the ability of aqueous solutions to spread on a hydrophobic surface. Furthermore, we discovered that PLUNC significantly reduced surface tension at the air-liquid interface in aqueous solutions, indicating novel and biologically relevant surfactant properties. Of note, surface tensions achieved by adding PLUNC to solutions are very similar to measurements of the surface tension in tracheobronchial secretions from humans and animal models. Because surfactants of microbial origin can disperse matrix-encased bacterial clusters known as biofilms [1], we hypothesized that PLUNC may also have anti-biofilm activity. We found that, at a physiologically relevant concentration, PLUNC inhibited biofilm formation by the airway pathogen Pseudomonas aeruginosa in an in vitro model.Conclusions/Significance
Our data suggest that the PLUNC protein contributes to the surfactant properties of airway secretions, and that this activity may interfere with biofilm formation by an airway pathogen. 相似文献999.
The quantification of changes in protein abundance in complex biological specimens is essential for proteomic studies in basic and applied research. Here we report on the development and validation of the DeepQuanTR software for identification and quantification of differentially expressed proteins using LC‐MALDI‐MS. Following enzymatic digestion, HPLC peptide separation and normalization of MALDI‐MS signal intensities to the ones of internal standards, the software extracts peptide features, adjusts differences in HPLC retention times and performs a relative quantification of features. The annotation of multiple peptides to the corresponding parent protein allows the definition of a Protein Quant Value, which is related to protein abundance and which allows inter‐sample comparisons. The performance of DeepQuanTR was evaluated by analyzing 24 samples deriving from human serum spiked with different amounts of four proteins and eight complex samples of vascular proteins, derived from surgically resected human kidneys with cancer following ex vivo perfusion with a reactive ester biotin derivative. The identification and experimental validation of proteins, which were differentially regulated in cancerous lesions as compared with normal kidney, was used to demonstrate the power of DeepQuanTR. This software, which can easily be used with established proteomic methodologies, facilitates the relative quantification of proteins derived from a wide variety of different samples. 相似文献
1000.